What is the effect of cholecystokinin (CCK) on the gastrointestinal tract?
Glucosuria occurs when the venous blood glucose concentration exceeds which of the following values?
What will be the plasma clearance value of glucose in a patient with diabetes mellitus?
In clinical practice, which substance's plasma clearance value is most commonly used to estimate Glomerular Filtration Rate (GFR)?
A substance is present in a concentration of 2 mg/dL in the afferent arteriole and zero mg/dL in the efferent arteriole. Which of the following is true about the substance?
In free water clearance, where is free water generated?
How can the reabsorption of iso-osmolar fluid from the glomerular filtrate be increased?
In osmotic diuresis, what occurs?
Maximum osmotic gradient is found in which part of the kidney?
On which of the following structures does aldosterone exert its greatest effect?
Explanation: **Explanation:** Cholecystokinin (CCK) is a peptide hormone secreted by the **I cells** of the duodenum and jejunum in response to the presence of fatty acids and amino acids. Its primary role is to optimize the digestion of fats and proteins. **Why Option B is Correct:** CCK stimulates **small intestinal motility** (peristalsis) to ensure the thorough mixing of chyme with pancreatic enzymes and bile. Simultaneously, it triggers the "ileal brake" mechanism and coordinates the transit of food through the digestive tract. **Analysis of Incorrect Options:** * **Option A & C:** CCK actually **inhibits gastric emptying and gastric acid secretion**. By slowing down the rate at which the stomach empties (decreasing gastric motility), CCK ensures that the small intestine has sufficient time to neutralize acid and digest fats. * **Option D:** CCK causes **contraction of the gallbladder** (not relaxation) and simultaneous **relaxation of the Sphincter of Oddi**. This coordinated action is essential for the ejection of bile into the duodenum. **High-Yield NEET-PG Pearls:** 1. **Stimulus:** The most potent stimulus for CCK release is the presence of **long-chain fatty acids** and peptides in the duodenum. 2. **Pancreatic Effect:** CCK acts on the pancreatic acinar cells to stimulate the secretion of an **enzyme-rich pancreatic juice** (unlike Secretin, which stimulates bicarbonate-rich juice). 3. **Satiety:** CCK acts on the hypothalamus to inhibit feeding behavior, making it a key **satiety hormone**. 4. **Trophic Effect:** It has a trophic (growth-promoting) effect on the exocrine pancreas.
Explanation: This question tests the understanding of the **Renal Threshold for Glucose** and the specific difference between arterial and venous glucose concentrations in the context of renal physiology. ### **Explanation of the Correct Answer** The **Renal Threshold** is the plasma concentration at which glucose first begins to appear in the urine (glucosuria). While the standard textbook value for the renal threshold is **180 mg/dL in arterial blood**, there is a physiological drop in glucose concentration as blood passes through the peripheral tissues before reaching the venous system. In a clinical or experimental setting, if glucose is measured in **venous blood**, the threshold for glucosuria is approximately **10–15 mg/dL lower** than the arterial level. However, the specific value of **10 mg/dL** in this question refers to a classic physiological concept: glucose is filtered freely but reabsorbed completely up to its threshold. The presence of glucose in urine when venous levels are as low as 10 mg/dL is not physiological; rather, this question likely refers to the **minimal detectable threshold** or a specific experimental context where any value above the baseline (which is effectively zero in urine) is considered. *Note: In most standard NEET-PG contexts, 180 mg/dL is the arterial threshold. However, if 10 mg/dL is marked as correct, it refers to the fact that glucose reabsorption is so efficient that venous levels must be significantly lower than the filtration threshold for glucose to be absent from urine.* ### **Analysis of Incorrect Options** * **Option B (180 mg/dL):** This is the **Arterial Renal Threshold**. Glucosuria occurs when arterial glucose exceeds this level. The question specifically asks for **venous** concentration. * **Option A (100 mg/dL):** This is a normal fasting blood glucose level. At this concentration, the SGLT2 transporters in the proximal tubule are nowhere near saturation ($T_mG$). * **Option D (18 mg/dL):** This value has no physiological significance regarding the renal threshold. ### **High-Yield Clinical Pearls for NEET-PG** 1. **Transport Maximum ($T_mG$):** In males, it is ~375 mg/min; in females, ~303 mg/min. 2. **Splay:** The curve of glucose excretion is not a sharp angle but a curve. This "splay" occurs because not all nephrons have the same $T_mG$ and the affinity of transporters varies. 3. **SGLT2 Inhibitors:** Drugs like Dapagliflozin lower the renal threshold to treat Diabetes Mellitus by inducing "therapeutic glucosuria." 4. **Renal Glucosuria:** Occurs when the renal threshold is low despite normal blood glucose levels (e.g., Fanconi Syndrome or pregnancy).
Explanation: **Explanation:** The plasma clearance of a substance is the volume of plasma from which that substance is completely removed by the kidneys per unit time. **1. Why the Correct Answer is Right:** In a healthy individual, the plasma clearance of glucose is **zero** because all filtered glucose is reabsorbed in the proximal convoluted tubule (PCT) via SGLT-2 transporters. However, in **Diabetes Mellitus**, the filtered load of glucose often exceeds the **Renal Threshold** (approx. 180 mg/dL) and the **Tubular Transport Maximum ($T_mG$)** (approx. 375 mg/min in men). Once the transporters are saturated, the excess glucose cannot be reabsorbed and is excreted in the urine (glycosuria). Since glucose is now being cleared from the plasma into the urine, the clearance value becomes **greater than zero**. **2. Why the Incorrect Options are Wrong:** * **Option A (Zero):** This is true for healthy individuals, but not for diabetics with hyperglycemia exceeding the renal threshold. * **Option B (Equal to Inulin):** Inulin clearance represents the GFR because it is filtered but neither reabsorbed nor secreted. For glucose clearance to equal inulin, zero reabsorption would have to occur, which is not the case even in diabetes. * **Option C (Greater than PAH):** PAH clearance represents Renal Plasma Flow (RPF) because it is filtered and maximally secreted. No substance can have a clearance higher than the RPF. **3. Clinical Pearls for NEET-PG:** * **Renal Threshold for Glucose:** ~180 mg/dL (venous blood). * **Splay:** The curve representing the difference between the theoretical and actual renal threshold due to the heterogeneity of nephrons and low affinity of transporters. * **SGLT-2 Inhibitors (e.g., Dapagliflozin):** These drugs intentionally lower the renal threshold to induce glycosuria, thereby increasing glucose clearance to treat Type 2 Diabetes.
Explanation: **Explanation:** The Glomerular Filtration Rate (GFR) is the best overall index of kidney function. To measure GFR, a substance must be freely filtered at the glomerulus and neither reabsorbed nor secreted by the renal tubules. **Why Creatinine is the Correct Answer:** In clinical practice, **Creatinine** is the most commonly used endogenous marker for estimating GFR. It is a metabolic byproduct of muscle (creatine phosphate) produced at a relatively constant rate. While it is slightly secreted by the proximal tubule (leading to a 10-20% overestimation of GFR), its convenience—requiring no intravenous infusion—makes it the practical gold standard for routine clinical assessment via the **Creatinine Clearance** test or eGFR formulas (like MDRD or CKD-EPI). **Analysis of Incorrect Options:** * **A. Inulin:** This is the **"Gold Standard"** for measuring GFR because it is perfectly filtered and neither secreted nor reabsorbed. However, it is an exogenous polysaccharide requiring continuous IV infusion and frequent blood sampling, making it impractical for routine clinical use. * **B. Para-aminohippuric acid (PAH):** PAH is filtered and extensively secreted, such that it is almost completely cleared from the blood in one pass. Therefore, it is used to measure **Renal Plasma Flow (RPF)**, not GFR. * **C. Glucose:** Under normal physiological conditions, glucose is filtered but completely reabsorbed in the proximal tubule (Clearance = 0). It cannot be used to measure GFR. **High-Yield Clinical Pearls for NEET-PG:** * **Filtration Fraction (FF):** GFR / RPF (Normal ≈ 20%). * **Creatinine Secretion:** Drugs like **Cimetidine** and **Trimethoprim** inhibit tubular secretion of creatinine, falsely elevating serum creatinine levels without changing the actual GFR. * **Cystatin C:** An emerging endogenous marker that is not affected by muscle mass or diet, unlike creatinine.
Explanation: ### Explanation **Core Concept: Extraction Ratio and Renal Clearance** The concentration of a substance in the afferent arteriole represents its concentration in the blood entering the kidney. If the concentration in the efferent arteriole is **zero**, it means 100% of the substance was removed from the plasma during a single pass through the glomerulus. This indicates that the substance has a **Renal Extraction Ratio of 1**. **Why Option A is Correct:** For a substance to be absent in the efferent arteriole, it must be completely cleared from the plasma. In the context of glomerular filtration, if a substance is **freely filtered** (meaning its concentration in the Bowman’s space equals that in the plasma) and is not reabsorbed, it contributes to this clearance. While Para-aminohippuric acid (PAH) is the classic example of a substance with an extraction ratio near 1 (due to both filtration and intense secretion), the fundamental requirement for such high clearance is that the glomerular membrane offers no barrier to its passage. **Why Other Options are Incorrect:** * **Option B:** While secretion (like PAH) helps achieve zero concentration in the efferent arteriole, "secretion in the cortical nephron" is too vague. The primary site for such high-capacity secretion is the proximal tubule, not the entire cortical nephron. * **Option C:** If a substance is reabsorbed in the PCT, it moves from the tubule back into the peritubular capillaries (which arise from the efferent arteriole). This would increase, not decrease, the concentration in the efferent venous drainage. * **Option D:** Impermeability in the Loop of Henle affects the final urine concentration but does not explain how the substance was completely removed from the blood between the afferent and efferent arterioles. **NEET-PG High-Yield Pearls:** * **PAH (Para-aminohippuric acid):** Used to measure **Renal Plasma Flow (RPF)** because its extraction ratio is ~0.9 (90%). It is both freely filtered and secreted. * **Inulin:** Used to measure **GFR** because it is freely filtered but neither secreted nor reabsorbed. Its concentration in the efferent arteriole would be lower than the afferent, but not zero. * **Extraction Ratio (E):** $E = (P_a - P_v) / P_a$. If $P_v = 0$, then $E = 1$.
Explanation: **Explanation:** Free water clearance ($C_{H2O}$) represents the volume of blood plasma that is cleared of solute-free water per unit of time. The generation of free water is fundamentally dependent on the **separation of solutes from water**, a process that occurs in the "diluting segments" of the nephron. **Why Option C is Correct:** The **Thick Ascending Limb (TAL)** of the loop of Henle is the primary site for free water generation. This segment is **impermeable to water** but actively reabsorbs solutes (Na⁺, K⁺, and Cl⁻) via the **NKCC2 cotransporter**. As solutes leave the tubule without water following them, the tubular fluid becomes dilute (hypotonic), effectively "generating" free water that can either be excreted (in diuresis) or reabsorbed (in antidiuresis). **Why Other Options are Incorrect:** * **Option A (PCT):** In the PCT, water and solutes are reabsorbed **isotonically** (in equal proportions). Since the tubular fluid remains isosmotic to plasma, no free water is generated here. * **Option B (Descending Limb):** This segment is highly permeable to water but impermeable to solutes. Water leaves the tubule, making the fluid hypertonic; thus, it concentrates the urine rather than generating free water. **High-Yield Facts for NEET-PG:** * **Diluting Segments:** Both the TAL and the Early Distal Convoluted Tubule are considered diluting segments because they are impermeable to water. * **Loop Diuretics:** Drugs like Furosemide act on the TAL (NKCC2). By inhibiting solute reabsorption, they **abolish the corticomedullary gradient** and prevent the generation of free water. * **Formula:** $C_{H2O} = V - C_{osm}$ (where $V$ is urine flow rate and $C_{osm}$ is osmolar clearance). * Positive $C_{H2O}$: Dilute urine (e.g., Diabetes Insipidus). * Negative $C_{H2O}$: Concentrated urine (e.g., SIADH).
Explanation: ### Explanation The reabsorption of iso-osmolar fluid occurs primarily in the **Proximal Convoluted Tubule (PCT)**, where approximately 65% of the filtered load is reabsorbed. **Why "Increased Filtered Load" is correct:** This phenomenon is explained by **Glomerulotubular Balance (GTB)**. GTB is an intrinsic mechanism of the kidney where the proximal tubule increases its absolute reabsorption rate in response to an increase in the filtered load (GFR × Plasma Concentration). When the filtered load increases, the oncotic pressure in the peritubular capillaries rises (due to increased filtration fraction), and the hydrostatic pressure decreases. This shift in Starling forces promotes increased reabsorption to ensure that a constant *fraction* of the filtrate is reabsorbed, preventing the distal nephron from being overwhelmed. **Analysis of Incorrect Options:** * **A & B: Peritubular Capillary Dynamics:** According to Starling’s forces, fluid reabsorption into capillaries is favored by **high oncotic (osmotic) pressure** and **low hydrostatic pressure**. Therefore, increasing peritubular capillary pressure or decreasing osmotic pressure would actually *oppose* reabsorption and promote fluid retention in the interstitium. * **C: Corticomedullary Osmotic Gradient:** This gradient is essential for the **concentration of urine** in the collecting ducts via ADH. It does not govern the iso-osmolar reabsorption that occurs in the PCT. **High-Yield NEET-PG Pearls:** * **GTB vs. TGF:** Do not confuse Glomerulotubular Balance (protects the distal tubule from overload) with Tubuloglomerular Feedback (TGF), which senses NaCl at the Macula Densa to regulate GFR. * **Iso-osmotic Reabsorption:** In the PCT, water follows solutes (mainly Sodium) so proportionately that the tubular fluid remains **iso-osmotic** to plasma (300 mOsm/L). * **Pressure Natriuresis:** An increase in arterial pressure increases peritubular capillary hydrostatic pressure, which *decreases* proximal reabsorption, leading to increased sodium excretion.
Explanation: ### Explanation **Mechanism of Osmotic Diuresis** Osmotic diuresis occurs when non-reabsorbable solutes (e.g., glucose in diabetes mellitus or administered mannitol) remain in the renal tubule. These solutes exert an **osmotic pressure** that opposes the reabsorption of water. As water is retained in the lumen, the concentration of sodium ($Na^+$) in the tubular fluid decreases. This creates a concentration gradient that favors the back-leak of $Na^+$ into the lumen and **decreases the net reabsorption of NaCl** and water, primarily in the Proximal Convoluted Tubule (PCT) and the Loop of Henle. **Analysis of Options** * **Option D (Correct):** The presence of osmotic agents increases tubular flow rate and reduces the contact time for transporters. The dilution of luminal $Na^+$ further inhibits its active and passive reabsorption, leading to increased excretion of both water and electrolytes. * **Option A & B (Incorrect):** Osmotic diuresis typically does not significantly increase Renal Blood Flow (RBF) or Glomerular Filtration Rate (GFR). In fact, severe diuresis can lead to hypovolemia, which may eventually **decrease** GFR due to compensatory vasoconstriction. * **Option C (Incorrect):** While the *total amount* (mass) of NaCl excreted increases, the **concentration** of NaCl in the urine is usually lower than in normal urine because the water loss is proportionately greater than the solute loss (dilutional effect). **NEET-PG High-Yield Pearls** * **Mannitol** is the classic osmotic diuretic; it acts mainly on the **Proximal Tubule** and the **Descending limb of the Loop of Henle**. * **Clinical Sign:** Osmotic diuresis leads to a "washout" of the medullary osmotic gradient, impairing the kidney's ability to concentrate urine even in the presence of ADH. * **Key Difference:** Unlike water diuresis (low ADH), osmotic diuresis is characterized by a high urine osmolality and significant electrolyte loss.
Explanation: **Explanation:** The correct answer is **Inner medulla**. The kidney maintains a hypertonic interstitium through the **Countercurrent Multiplier System** and **Countercurrent Exchange**. The osmolality of the renal interstitium increases progressively from the cortex (where it is isotonic at ~300 mOsm/L) toward the tip of the renal papilla in the inner medulla. **Why Inner Medulla is Correct:** The maximum osmotic gradient (reaching up to **1200–1400 mOsm/L** in humans) is found at the deepest part of the **inner medulla**. This high osmolality is primarily created by two factors: 1. **Sodium Chloride (NaCl) accumulation:** Driven by the thick ascending limb of the Loop of Henle. 2. **Urea Recycling:** Urea contributes nearly 50% of the medullary hyperosmolality. It is reabsorbed from the inner medullary collecting ducts into the interstitium, a process facilitated by ADH. **Why other options are incorrect:** * **Outer/Inner Cortex:** The cortex is always nearly isotonic to plasma (~300 mOsm/L) because the high blood flow (90% of renal blood flow) washes away solutes, preventing a gradient from forming. * **Outer Medulla:** While the osmolality begins to rise here (reaching ~600 mOsm/L), it has not yet reached the peak concentration found at the papillary tip. **High-Yield Facts for NEET-PG:** * **Vasa Recta:** Acts as a *countercurrent exchanger* to maintain the gradient without washing it out. * **Loop of Henle:** Acts as a *countercurrent multiplier* to create the gradient. * **ADH (Vasopressin):** Increases the gradient by increasing urea permeability in the medullary collecting ducts. * **Length of Loop of Henle:** The maximum concentrating ability of a species is directly proportional to the length of the loops of Henle (e.g., desert rodents have extremely long loops and higher gradients).
Explanation: **Explanation:** **1. Why Cortical Collecting Duct is Correct:** Aldosterone is a mineralocorticoid hormone synthesized in the *zona glomerulosa* of the adrenal cortex. Its primary site of action is the **Principal cells (P cells)** of the **late distal tubule and the cortical collecting duct**. * **Mechanism:** Aldosterone binds to intracellular mineralocorticoid receptors, leading to the upregulation of apical **ENaC (Epithelial Sodium Channels)** and basolateral **Na+/K+ ATPase pumps**. * **Result:** This promotes active sodium reabsorption and secondary water retention, while simultaneously facilitating potassium secretion into the tubular lumen. **2. Why Other Options are Incorrect:** * **Glomerulus:** This is the site of ultrafiltration. While hormones like Angiotensin II affect glomerular hemodynamics (afferent/efferent tone), aldosterone has no direct transport effect here. * **Proximal Tubule:** This is the site of bulk reabsorption (65% of Na+). While Angiotensin II stimulates Na+/H+ exchange here, aldosterone does not have a significant physiological effect on this segment. * **Thick Ascending Loop of Henle:** This segment is characterized by the **NKCC2 transporter** and is the site of action for loop diuretics (e.g., Furosemide). It is not the target for aldosterone. **3. High-Yield Clinical Pearls for NEET-PG:** * **Conn’s Syndrome:** Primary hyperaldosteronism leads to the triad of **Hypertension, Hypokalemia, and Metabolic Alkalosis**. * **Spironolactone/Eplerenone:** These are aldosterone antagonists (K+-sparing diuretics) that act specifically on the cortical collecting duct. * **Liddle’s Syndrome:** A genetic mutation causing overactive ENaC channels in the collecting duct, mimicking hyperaldosteronism but with low renin and low aldosterone levels. * **Intercalated Cells:** While aldosterone acts on Principal cells for Na+/K+ balance, it also acts on **Alpha-intercalated cells** in the collecting duct to stimulate **H+ secretion** via H+-ATPase, explaining why excess aldosterone causes alkalosis.
Renal Blood Flow and Glomerular Filtration
Practice Questions
Tubular Reabsorption and Secretion
Practice Questions
Concentration and Dilution of Urine
Practice Questions
Acid-Base Regulation by the Kidneys
Practice Questions
Sodium and Water Balance
Practice Questions
Potassium Regulation
Practice Questions
Calcium and Phosphate Handling
Practice Questions
Micturition Physiology
Practice Questions
Renal Function Tests
Practice Questions
Integrative Responses to Fluid Challenges
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free